🚀 VC round data is live in beta, check it out!
Largest BioTech Public Companies in Sweden
Benchmark revenue and EBITDA valuation multiples for public comps like
Sobi, Camurus, BioArctic, Elekta and BoneSupport.
 | $46 | +45% | $16B | $17B | 5.3x | 13.5x | ||
| $63 | -6% | $4B | $3B | 12.5x | 31.9x | ||
| $35 | +65% | $3B | $3B | 14.6x | 27.4x | ||
| $6 | +20% | $2B | $3B | 1.6x | 9.6x | ||
| $29 | -14% | $2B | $2B | 13.4x | 58.5x | ||
| $13 | +20% | $1B | $1B | 7.2x | 24.2x | ||
| $3 | -26% | $494M | $679M | 2.2x | 11.3x | ||
| $32 | -- | $362M | $338M | — | — | ||
| $1 | +28% | $324M | $197M | 426.1x | (4.1x) | ||
| $3 | +10% | $315M | $341M | 12.8x | (6.3x) | ||
| $3 | -31% | $252M | $188M | — | — | ||
| $1 | +43% | $228M | $214M | 10.1x | (12.9x) | ||
| $1 | -23% | $209M | $214M | — | (22.1x) | ||
| $6 | -26% | $187M | $230M | 4.8x | 24.3x | ||
| $1 | +97% | $164M | $162M | — | — | ||
| $0 | -- | $163M | $43M | — | — | ||
| $2 | -28% | $160M | $96M | 3.6x | (2.8x) | ||
| $2 | -15% | $144M | $134M | 9.0x | 32.2x | ||
| $3 | -16% | $134M | $133M | 44.9x | (6.6x) | ||
| $0 | +28% | $124M | $112M | 128.3x | (23.6x) | ||
| $0 | +152% | $110M | $104M | 4.1x | 16.6x | ||
| $1 | -4% | $105M | $96M | 4.2x | (94.1x) | ||
| $2 | -14% | $104M | $99M | — | (13.4x) | ||
| $2 | +75% | $87M | $35M | 7.0x | (1.3x) | ||
| $0 | +19% | $83M | $75M | — | — | ||
| $2 | +35% | $80M | $34M | 12.6x | (1.2x) | ||
| $6 | -12% | $79M | $63M | — | (6.6x) | ||
| $0 | +144% | $76M | $72M | — | — | ||
| $0 | -5% | $73M | $69M | 11.6x | — | ||
| $0 | -16% | $60M | $65M | 6.0x | (2.9x) | ||
| $0 | -9% | $56M | $109M | 1.2x | 3.9x | ||
| $1 | +35% | $54M | $29M | 16.0x | (10.8x) | ||
| $2 | +56% | $46M | $44M | 21.6x | (76.4x) | ||
| $0 | +1% | $45M | $40M | 14.1x | (8.5x) | ||
| $0 | +16% | $44M | $27M | 8.9x | (3.8x) | ||
| $0 | +466% | $39M | $25M | 1.6x | 3.0x | ||
| $0 | +154% | $36M | $32M | — | — | ||
| $1 | +0% | $34M | $28M | 72.4x | (2.4x) | ||
| $2 | -9% | $32M | $32M | — | — | ||
| $0 | +5% | $29M | $31M | — | — | ||
| $1 | +26% | $28M | $25M | — | (25.5x) | ||
| $0 | -31% | $26M | $24M | 41.6x | (3.5x) | ||
| $1 | -52% | $26M | $23M | 1.4x | (5.7x) | ||
| $0 | -55% | $25M | $12M | — | (1.8x) | ||
| $0 | +15% | $21M | $14M | 20.5x | (3.5x) | ||
| $0 | +18% | $21M | $18M | 80.5x | (8.2x) | ||
| $0 | -84% | $21M | $19M | — | (1.9x) | ||
| $0 | -85% | $21M | $10M | — | (0.5x) | ||
| $1 | +139% | $20M | $19M | — | — | ||
| $0 | -37% | $18M | $12M | — | (2.4x) | ||
| $0 | +25% | $16M | $13M | 8.1x | (3.8x) | ||
| $1 | -19% | $16M | $13M | — | — | ||
| $0 | -76% | $14M | $9M | 1.1x | (1.1x) | ||
| $0 | +5% | $13M | $14M | — | — | ||
| $2 | -48% | $11M | $7M | 3.0x | (3.2x) | ||
| $0 | +10% | $11M | $10M | — | — | ||
| $0 | -47% | $11M | $2M | 1.3x | (0.3x) | ||
| $0 | -38% | $11M | $10M | — | — | ||
| $1 | +30% | $10M | $10M | — | — | ||
| $0 | -70% | $10M | $8M | — | (2.3x) | ||
| $0 | +56% | $10M | $9M | — | — | ||
| $0 | -61% | $9M | $11M | — | (2.9x) | ||
| $0 | -85% | $9M | $45M | — | — | ||
| $0 | -32% | $9M | $8M | — | — | ||
| $0 | -46% | $9M | $11M | — | — | ||
| $0 | -11% | $9M | $5M | — | (1.7x) | ||
| $1 | +30% | $8M | $8M | — | — | ||
| $0 | -- | $8M | $7M | — | — | ||
| $0 | +48% | $8M | $7M | — | — | ||
| $0 | -18% | $7M | $6M | 7.3x | (5.6x) | ||
| $0 | -13% | $6M | $4M | — | — | ||
| $0 | -58% | $4M | $3M | — | — | ||
| $0 | +68% | $3M | $3M | — | — | ||
| $0 | -56% | $3M | $3M | — | — | ||
| $0 | -91% | $3M | ($3M) | — | — | ||
| $1 | -66% | $3M | $908K | — | — | ||
| $0 | -88% | $3M | $2M | — | — | ||
| $0 | -88% | $2M | ($3M) | — | — | ||
| $0 | -67% | $2M | $3M | — | — | ||
| $2 | +17% | $2M | ($252K) | — | — | ||
| $0 | -7% | $2M | $2M | — | (2.1x) | ||
| $0 | -51% | $2M | $1M | — | — | ||
| $0 | -70% | $1M | $1M | — | — | ||
| $0 | -69% | $1M | $2M | — | — | ||
| $0 | -70% | $994K | $763K | — | — | ||
| $0 | -71% | $893K | $746K | — | (4.1x) | ||
| $0 | -90% | $641K | $536K | — | — | ||
| $0 | -- | $371K | ($839K) | — | — | ||
| $0 | -- | $309K | $308K | — | — | ||
| $0 | -96% | $290K | ($2M) | — | — |
Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.